BioCentury
ARTICLE | Clinical News

MDX-1100: Phase II started

May 19, 2008 7:00 AM UTC

Medarex began a double-blind, placebo-controlled, international Phase II trial to evaluate 10 mg/kg MDX-1100 given every other week for 8 weeks in 106 patients. ...